Envoy Medical, Inc.

Envoy Medical, Inc. (Nasdaq: ANZU) is a medical device company focused on hearing health, best known for its Esteem fully implanted active middle ear implant for patients with sensorineural hearing loss. The company went public through a business combination with Anzu Special Acquisition Corp I, a blank-check company sponsored by Anzu Partners, which completed its IPO in 2021 and closed the merger with Envoy Medical in September 2023. Operating in the medical device and hearing healthcare sector, Envoy Medical filed an 8-K with the SEC on June 3, 2025, reporting a material corporate development. Visitors seeking complete filing history, event timelines, and deal analytics for ANZU can access the full dataset by signing up at SpacDesk.